Chapter 869

Now the world knows that the patent of specific drugs is in China, and only China can export such drugs. Once restricted, it will weaken its international influence in a disguised form.

Finally, when all this is achieved, Jiang Fuyue will also be nailed to the pillar of shame!

What a vicious calculation!

Off stage, the live broadcast is in progress.

Experts from various countries also concentrate. Some people take out their work computers directly and start abstracting, while others use the most primitive method to record on paper.

After Hamasaki finished, some of them nodded and others shook their heads. However, most of them remained neutral and did not make a statement.

Of course, discussions are inevitable.

"If there is no problem with the experimental data of Hamasaki Kawasaki, the final conclusion will not be too far away."

"Therefore, whether the experimental data, especially the human sample data of clinical trials, are credible is the key to judge whether the final conclusion is correct."

"I agree with that."

"I agree."

"But now the problem is that clinical experimental data are not more difficult to obtain than animal experimental data, and are greatly affected by individual differences. It is not easy to exclude interference items during analysis."

“……”

Therefore, the focus of debate under the stage has become the discussion of whether the clinical data are credible.

Note that it is "credibility", not "authenticity".

So far, no one doubts that there may be a problem with the experimental data of Hamasaki Kawasaki.

After all, no matter how mediocre and unproductive a research scholar is, if he still has a little professional quality, he should also know that the most basic thing in the experimental process is to ensure the authenticity of the data.

Because of their subconscious trust in Hamasaki, they took the initiative to break their eyes because——

Jiang Fuyue spoke.

"Before formally refuting professor Hamasaki's point of view, I would like to ask you to look at these two clinical trial data analysis reports."

It appears immediately on the screen.

"You can see that pregnant women of the same age, similar physical data indicators and the same drug dosage basically copy the individual sample one by one, and control all variables. However, the final result is quite the opposite!"

WOW——

Instant fryer under the stage.

"How could this happen?"

"The data are the same, the analysis methods are the same, and the final conclusion is the opposite? What's the reason?"

"Shouldn't..."

At this time, Hamasaki's expression was slightly sluggish, subconsciously sat up straight and looked at Jiang Fuyue for the first time.

Suddenly, the girl looked at him. They collided. Hamasaki Kawashima's eyes narrowed slightly, but she smiled: "Professor Hamasaki, why do you say this?"

Hamasaki calmly picked up the microphone: "first of all, there are differences in the human body. Although the samples you listed are roughly similar to the samples I used, they are not exactly the same, that is, there are errors in the control variables. Therefore, it is only possible that your samples have problems or the analysis steps are not rigorous enough!"

"Secondly, I use the vertical plus longitudinal analysis method, which involves the elimination of influencing factors. This is replaced by only one sentence in the paper. You may not have noticed, resulting in the omission of this step in the retest."

After all, whether it is the sample itself or the analysis steps, the problem lies in Jiang Fuyue!

"Really?" Jiang Fuyue was not annoyed by being questioned on the spot, but raised a smile. "But I still have the second, third or even more data reports here. The conclusion is still different from you? Why?"